Literature DB >> 333548

In vitro TNP-specific antibody formation by peripheral lymphocytes from patients with systemic lupus erythematosus.

C Morimoto, T Abe, M Hara, M Homma.   

Abstract

Immunological reactivity in patients with systemic lupus erythermatosus (SLE) was assessed by investigating in vitro trinitrophenyl (TNP)-specific antibody formation by peripheral lymphocytes. Peripheral lymphocytes from 16 patients with SLE were cultured with TNP conjugated with horse erythrocytes (TNP-HRBC) in the presence of 2-mercaptoethanol. The hemolytic plaque assay was used to detect hapten (TNP)-specific antibody-forming cells. Peripheral lymphocytes from normal individuals failed to produce antibody to TNP, whereas SLE lymphocytes produced a significant number of plaque-forming cells. Co-culture experiments with SLE and normal lymphocytes suggested that patients with SLE have a defect in T lymphocytes, leading to abnormal antibody production.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 333548     DOI: 10.1111/j.1365-3083.1977.tb02135.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  11 in total

1.  Accessory cell activity of monocytes in anti-DNA antibody production in systemic lupus erythematosus.

Authors:  T Sasaki; S Shibata; Y Hirabayashi; Y Sekiguchi; K Yoshinaga
Journal:  Clin Exp Immunol       Date:  1989-07       Impact factor: 4.330

2.  Studies of immune functions of patients with systemic lupus erythematosus. Complement-dependent immunoglobulin M anti-thymus-derived cell antibodies preferentially inactivate suppressor cells.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

3.  Loss of suppressor T-lymphocyte function in patients with systemic lupus erythematosus (SLE).

Authors:  C Morimoto
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

4.  Defective B cell function in systemic lupus erythematosus.

Authors:  B K Pelton; A M Denman
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

5.  Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.

Authors:  T Sakane; A D Steinberg; J P Reeves; I Green
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

6.  Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.

Authors:  H M Moutsopoulos; A S Fauci
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

7.  Depressed primary in vitro antibody response in untreated systemic lupus erythematosus. T helper cell defect and lack of defective suppressor cell function.

Authors:  J F Delfraissy; P Segond; P Galanaud; C Wallon; P Massias; J Dormont
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

8.  Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus.

Authors:  C Morimoto; E L Reinherz; S F Schlossman; P H Schur; J A Mills; A D Steinberg
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

9.  In vitro nucleoside specific immune response by lymphocytes from systemic lupus erythematosus.

Authors:  C Morimoto; A D Steinberg; S F Schlossman; Y Borel
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

10.  A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody.

Authors:  C Morimoto; A D Steinberg; N L Letvin; M Hagan; T Takeuchi; J Daley; H Levine; S F Schlossman
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.